Viatris, Inc. (VTRS)
20.84
+0.17
(+0.82%)
USD |
NASDAQ |
Nov 13, 16:00
20.75
-0.09
(-0.43%)
After-Hours: 19:59
Viatris EPS Diluted (Quarterly) : -0.2832 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.2832 |
| June 30, 2026 | -0.1021 |
| March 31, 2026 | 0.1501 |
| December 31, 2025 | -0.2951 |
| September 30, 2025 | -0.1101 |
| June 30, 2025 | -0.0039 |
| March 31, 2025 | -2.551 |
| December 31, 2024 | -0.4327 |
| September 30, 2024 | 0.079 |
| June 30, 2024 | -0.274 |
| March 31, 2024 | 0.0942 |
| December 31, 2023 | -0.638 |
| September 30, 2023 | 0.2746 |
| June 30, 2023 | 0.2194 |
| March 31, 2023 | 0.1864 |
| December 31, 2022 | 0.8279 |
| September 30, 2022 | 0.2909 |
| June 30, 2022 | 0.2579 |
| March 31, 2022 | 0.3291 |
| December 31, 2021 | -0.2181 |
| September 30, 2021 | 0.2569 |
| June 30, 2021 | -0.231 |
| March 31, 2021 | -0.8593 |
| December 31, 2020 | -1.07 |
| September 30, 2020 | 0.3587 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.0762 |
| March 31, 2020 | 0.0402 |
| December 31, 2019 | 0.0397 |
| September 30, 2019 | 0.3677 |
| June 30, 2019 | -0.3269 |
| March 31, 2019 | -0.0485 |
| December 31, 2018 | 0.0991 |
| September 30, 2018 | 0.3421 |
| June 30, 2018 | 0.0726 |
| March 31, 2018 | 0.1685 |
| December 31, 2017 | 0.46 |
| September 30, 2017 | 0.16 |
| June 30, 2017 | 0.55 |
| March 31, 2017 | 0.1237 |
| December 31, 2016 | 0.78 |
| September 30, 2016 | -0.23 |
| June 30, 2016 | 0.33 |
| March 31, 2016 | 0.03 |
| December 31, 2015 | 0.38 |
| September 30, 2015 | 0.83 |
| June 30, 2015 | 0.32 |
| March 31, 2015 | 0.13 |
| December 31, 2014 | 0.47 |
| September 30, 2014 | 1.26 |
| June 30, 2014 | 0.32 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pacira Biosciences, Inc. | 0.6985 |
| Pfizer Inc. | 0.5637 |
| Eli Lilly & Co. | 7.221 |
| Merck & Co., Inc. | 2.044 |
| Amphastar Pharmaceuticals, Inc. | 0.8706 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -325.30M |
| Revenue (Quarterly) | 3.752B |
| Total Expenses (Quarterly) | 4.077B |
| Enterprise Value | 35.38B |
| Gross Profit Margin (Quarterly) | 41.68% |
| Profit Margin (Quarterly) | -8.67% |
| Earnings Yield | -2.54% |
| Operating Earnings Yield | 6.55% |
| Normalized Earnings Yield | 2.248 |